BLFSBioLife Solutions, Inc.
What is the market doing?
No clear lean: nothing decisive, though in an uptrend.
In an uptrend, above its rising 50- and 200-day averages. Price is +47% vs its 200-day average.
Heavily shorted, settled Sep 15, 2026, about a week of normal trading to cover. Down 1.1% since the previous count, up from 7.4% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How BLFS is trading
BioLife Solutions, Inc. is +50% over the past year while the S&P 500 is +18%: 31 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +47%
vs 200-day average · a clear uptrend
- RSI (14)
- 62
RSI (14) · neutral
- Below its 52-week high
- 1.7%
Below its 52-week high
Details›
- Last close2026-10-05
- $38.58
- 1 monthS&P 500 +2.7%
- +8.6%
- 1 yearS&P 500 +18%
- +50%
- 5 yearsS&P 500 +88%
- −27%
- vs 50-day average$35.48
- +8.7%
- 52-week high
- $39.24
- 52-week low
- $18.15
- Annualised volatility
- 50%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$28M
| Year | Return |
|---|---|
| 2026 (year to date) | +60% |
| 2025 | −6.9% |
| 2024 | +60% |
| 2023 | −11% |
| 2022 | −51% |
| 2021 | −6.6% |
| 2020 | +147% |
| 2019 | +34% |
| 2018 | +100% |
| 2017 | +273% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +1.6% |
| Feb | 10 | 5 of 10 | +1.3% |
| Mar | 10 | 2 of 10 | −6.6% |
| Apr | 10 | 4 of 10 | −0.98% |
| May | 10 | 8 of 10 | +18% |
| Jun | 10 | 5 of 10 | +5.0% |
| Jul | 11 | 9 of 11 | +21% |
| Aug | 11 | 9 of 11 | +11% |
| Sep | 11 | 6 of 11 | −0.77% |
| Oct | 11 | 5 of 11 | −3.1% |
| Nov | 10 | 3 of 10 | +1.2% |
| Dec | 10 | 5 of 10 | +1.7% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Medical Instruments & Supplies
Ranks #18 of 21 by RyuScore